-
BCA Protein Quantification Kit K4102 Guide
2026-09-09
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports sensitive total-protein measurement when dilute samples, cell lysates, or detergent-containing preparations must be normalized. It is intended for scientific research workflows only and should not be used for diagnostic, clinical, or medical testing.
-
SWI/SNF ATPases in H3.3K27M DIPG
2026-09-09
This PNAS study identifies increased SWI/SNF ATPase activity as a vulnerability in H3.3K27M diffuse intrinsic pontine glioma models. Degrading SMARCA4, SMARCA2, and PBRM1 with AU-15330 reduced chromatin accessibility and FOXO1-associated survival programs, supporting a preclinical strategy for targeting chromatin remodeling in these tumors.
-
Engineered Esophagus: Functional Integration in Minipigs
2026-09-08
The reference study combines an autologous, cell-seeded decellularized scaffold with bioreactor conditioning, temporary intraluminal support, and vascularizing pleural coverage to repair circumferential esophageal defects in growing minipigs. Its most important contribution is evidence of progressive neuromuscular regeneration, vascularization, secondary peristalsis, and stent independence without immunosuppression, although translation to pediatric patients remains unresolved.
-
Spinal Astrocytic EAATs in Breakthrough Cancer Pain
2026-09-08
Jiang and colleagues developed a recurrent endothelin-1-triggered mouse model of breakthrough cancer pain and identified coordinated changes in spinal astrocytic EAAT1, EAAT2, and connexin 43 signaling. Their pharmacological experiments suggest that enhancing EAAT2 or blocking connexin 43-associated gap junction activity can reduce pain hypersensitivity, providing a mechanistic framework for future BTcP studies.
-
Standardized Whole-Blood Stimulation and Immunometabolism
2026-09-07
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines pathogen-relevant immune challenges with pharmacological metabolism modulation and cytokine measurement. The framework preserves donor blood complexity while improving the reproducibility and interpretability of cohort-scale immunometabolism studies.
-
Isoprinosine: Mechanism, Evidence, and Workflow
2026-09-07
Isoprinosine, also called inosine pranobex, is an immunomodulatory compound with reported antiviral activity against HHV-1 and clinical use in selected acute respiratory viral infections. This article separates product specifications from herpesvirus nuclear-egress biology and defines practical boundaries for laboratory interpretation.
-
CX-5461 Drives Mitotic Catastrophe in Cervical Cancer
2026-09-05
A June 2026 study identifies a distinct mechanism by which the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cells: Pol I inhibition is coupled to ATM/ATR-associated DNA damage, abnormal mitotic entry, and mitotic catastrophe. The findings also support testing CX-5461 with cisplatin, particularly in models of treatment-resistant disease, while highlighting the need for further validation beyond cell-based systems.
-
Rocket-Like Nanomedicine Reprograms PDAC Stroma
2026-09-04
Fu and colleagues developed an acid-responsive, sequential-release nanomedicine that remodels pancreatic ductal adenocarcinoma stroma before delivering gemcitabine. In a PDAC mouse model, the Si-G@Ca-H/uPA platform produced marked tumor regression without reported overt side effects, supporting stromal reprogramming as an alternative to nonspecific stromal depletion.
-
Predicting siRNA Encapsulation with Netarsudil
2026-09-04
Slaughter et al. introduce a quantitative framework for predicting when ionizable drugs can complex siRNA and function as drug-containing nanoparticle components. Netarsudil (AR-13324) served as an experimental validation agent, enabling codelivery of CTGF-targeting siRNA and reducing CTGF expression and actin-network density in fibrotic human trabecular meshwork cells.
-
Merbromin Assay Design: From Signal to Evidence
2026-09-03
Merbromin is a versatile biochemical research fluorescent dye and protein–ligand interaction probe. This guide shows how to translate its fluorescence, absorption, and resonance Rayleigh scattering behavior into better pharmaceutical, enzymatic, and antiviral assay decisions.
-
BRD4 Inhibitors Sensitize Cells to Erastin Ferroptosis
2026-09-03
The reference study shows that pharmacological BRD4 inhibition and BRD4 knockdown broadly enhance erastin-induced ferroptosis across several human cell lines. Its mechanistic contribution is the identification of increased reactive oxygen species and reduced FSP1 expression as convergent features, while also revealing cell-specific changes in other ferroptosis-associated genes.
-
Bafilomycin A1: From V-ATPase to Translation
2026-09-02
A mechanistic and translational framework for using Bafilomycin A1 to connect V-ATPase activity, intracellular pH regulation, lysosomal function, oxidative stress, and autophagy while preserving experimental rigor.
-
Platelet Extravasation in Tumors: CXCR4 and Growth
2026-09-02
The reference study defines platelet transendothelial migration into tumors as a regulated process controlled by CXCL12/CXCR4, FAK, PECAM-1, and vessel-stabilizing pathways. Its central contribution is to separate platelet trafficking from platelet effector activity, showing that distinct granule-release programs independently influence tumor growth and vascular integrity.
-
A Proximity MAP of RAB GTPases: Key Findings
2026-09-01
The preprint A Proximity MAP of RAB GTPases applies APEX2 proximity labeling across 23 human RAB GTPases to build a comparative map of their neighboring proteomes. Its validation of RAB25–DENND6A, RAB14–EARP, and RAB14–SHIP164/UHRF1BP1 relationships illustrates how proximity proteomics can generate testable models of membrane-trafficking regulation.
-
α2-AR Agonism in Osteosarcoma Research
2026-09-01
A translational perspective on how α2-adrenergic receptor activation may shift osteosarcoma recurrence research from direct tumor-cell killing toward immune-context engineering, with practical guidance for using B3465 in receptor, immune, and hydrogel-based studies.